×

Concerned about your own or
someone else’s drug use?

Generate

New evidence
based knowledge

NCCRED Clinical Research Funding

Allocated and available funding

Round 4 NCCRED Seed Funding Grant Applications are open !

NCCRED is opening a competitive round of seed funding grants to support innovative clinical research for the treatment of substance use disorder due to methamphetamine or emerging drugs of concern.

Round 4 Seed Funding Grants

Applications of between $5,000 to $100,000 per project will be considered with $200,000 available in Round 4 of funding! Applications close on 23rd April 2021

Focus of the funding round

The current funding round aims is to provide financial support in the form of:

  1. Seed-funding grants to establish investigator-initiated clinical research; or
  2. A value-add to research projects that are currently underway.

 

Projects must relate to methamphetamine or emerging drugs of concern and preference will be given to projects that address the research priorities outlined in the NCCRED seed funding round 4 guidelines and application form below.

Importantly, applicants are encouraged to apply for funding that will enable a study to:

  • Answer relevant clinical questions
  • Build research capacity
  • Produce translational research results (see criteria below for more details)

The grant should produce a fundable project that has the capacity to attract further funding (as required).

Key Dates

Applications open 18 Feb 21
Applications close 14 Apr 21
Applicants are notified of results 18 May 21
Final study report due to NCCRED 10 Jun 22

Key Dates

Applications open 18 Feb 21
Applications close 14 Apr 21
Applicants are notified of results 18 May 21
Final study report due to NCCRED 10 Jun 22

Applications

Applications are open to clinicians or clinical researchers (or teams of clinicians and researchers) from any background who are working in the Alcohol and Other Drugs and other healthcare sectors. Applications will ideally create networks or build partnerships (e.g. academic, clinical, consumer) to maximize reach and opportunities.

Grant applications will be reviewed by the independent NCCRED Methamphetamine and Emerging Drugs Working Group and presented to the NCCRED Board for support of funding.

For more information on the evaluation criteria of the grants, submission of the grants, to access the guidelines and the application form, please follow the link below.


Applicants considering submission should contact the NCCRED Clinical Research Lead, Krista Siefried, to discuss the grants further, discuss mentorship for assistance in conceptualising your project or developing your funding application, or for any questions you can email us via the link below.


Are you a clinician who is interested in applying for an NCCRED clinical research grant but aren’t sure where to start?

 

NCCRED hosted three introductory webinars for clinicians interested in clinical research.

 

  • An introduction to evidence-based practice for clinicians in the AOD sector
  • Introduction to Clinical Research for clinicians in the AOD sector
  • Introduction to Good Clinical Practice in Clinical Research (ICH-GCP E6 R(2)) for clinicians working in the AOD sector.

The webinars covered the fundamentals of establishing and conducting good clinical research, in an attempt to make the process accessible and attractive to new researchers.

Seed Funding Recipients: Round 3

A key objective of NCCRED is to provide seed-funding to establish new clinical trials and clinical research, in order to build capacity for clinical research in the Alcohol and Other Drug (AOD) sector.  Seed funding was granted through a formal application process with the level of funding determined by the NCCRED Board.

Rapid translation of forensic data from police drug seizures into clinical alerts to improve public health

Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.

Amount Awarded: $95,481.00

Rapid translation of forensic data from police drug seizures into clinical alerts to improve public health

Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.

Amount Awarded: $95,481.00

Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence

Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University

Amount awarded: $94,369.00

Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence

Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University

Amount awarded: $94,369.00

Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study

Principal Investigator: Prof Andrew Dawson, University of Sydney.

Amount awarded: $95,000.00

Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study

Principal Investigator: Prof Andrew Dawson, University of Sydney.

Amount awarded: $95,000.00

BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $61,342.00

BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $61,342.00

Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.

Principal Investigator: A/Prof Suzanne Nielson, Monash University

Amount awarded: $98,774.00

Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.

Principal Investigator: A/Prof Suzanne Nielson, Monash University

Amount awarded: $98,774.00

An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women

Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health

Amount awarded: $97,844.25

An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women

Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health

Amount awarded: $97,844.25

Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Principal Investigator: Dr Amy Peacock, University of New South Wales

Amount awarded: $96,120.00

Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Principal Investigator: Dr Amy Peacock, University of New South Wales

Amount awarded: $96,120.00

Seed Funding Recipients: Round 2

An open-label pilot study of sub-anaesthetic ketamine for methamphetamine abuse in young people.

Principal Investigator: Dr G Bedi, Orygen: The National Centre of Excellence in Youth Mental Health (Vic).

Amount awarded: $99,703.53.

An open-label pilot study of sub-anaesthetic ketamine for methamphetamine abuse in young people.

Principal Investigator: Dr G Bedi, Orygen: The National Centre of Excellence in Youth Mental Health (Vic).

Amount awarded: $99,703.53.

Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.

Principal Investigator: A/Prof P Kelly, University of Wollongong (NSW).

Amount awarded: $77,489.00.

Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.

Principal Investigator: A/Prof P Kelly, University of Wollongong (NSW).

Amount awarded: $77,489.00.

A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.

Principal Investigator: A/Prof V. Manning, Monash University (Vic).

Amount awarded: $97,595.30.

A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.

Principal Investigator: A/Prof V. Manning, Monash University (Vic).

Amount awarded: $97,595.30.

Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.

Principal Investigator: Dr R.Sutherland, The University of New South Wales (NSW).

Amount awarded: $38,795.00.

Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.

Principal Investigator: Dr R.Sutherland, The University of New South Wales (NSW).

Amount awarded: $38,795.00.

An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.

Principal Investigator: A/Prof J. Ward, South Australian Health and Medical Research Institute (SA).

Amount awarded: $68,400.00.

An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.

Principal Investigator: A/Prof J. Ward, South Australian Health and Medical Research Institute (SA).

Amount awarded: $68,400.00.

Seed Funding Recipients: Round 1

 

Round 1 Seed Funding and Capacity Building Grants Presentations

Recipients of Round 1 Seed Funding and Capacity Building Grants presented on their research at the 2019 NCCRED Symposium. You can view the Symposium program and watch the presentations on our website here

Emerging Drug Network of Australia (EDNA)

Principal Investigator: DJ.Soderstrom, Royal Perth Hospital (WA)

Amount awarded: $100,000.00

Emerging Drug Network of Australia (EDNA)

Principal Investigator: DJ.Soderstrom, Royal Perth Hospital (WA)

Amount awarded: $100,000.00

Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views

Principal Investigator: Dr B.Larance, University of Wollongong (NSW)

Amount awarded: $66,190.00.

Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views

Principal Investigator: Dr B.Larance, University of Wollongong (NSW)

Amount awarded: $66,190.00.

Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service

Principal Investigator: Dr C. Rodgers, St Vincent’s Hospital Sydney (NSW)

Amount awarded: $29,947.50

Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service

Principal Investigator: Dr C. Rodgers, St Vincent’s Hospital Sydney (NSW)

Amount awarded: $29,947.50

Capacity Building grants

NCCRED awarded one round of Capacity building grants to existing investigator-initiated methamphetamine treatment research to expand clinical research capacity and national reach.

Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project

Principal Investigator: Prof N. Lintzeris, South Eastern Sydney Local Health District (NSW) 

Amount awarded: $104,000.00 

Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project

Principal Investigator: Prof N. Lintzeris, South Eastern Sydney Local Health District (NSW) 

Amount awarded: $104,000.00 

The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

Principal Investigator: Prof P.Haber, Royal Prince Alfred Hospital (NSW) 

Amount awarded: $100,000.00 

The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

Principal Investigator: Prof P.Haber, Royal Prince Alfred Hospital (NSW) 

Amount awarded: $100,000.00 

South Australian drug early warning system  Emergency Department admission blood psychoactive testing

Principal Investigator: Dr P.Stockham, Forensic Science SA (SA) 

Amount awarded: $100,000.00    

South Australian drug early warning system  Emergency Department admission blood psychoactive testing

Principal Investigator: Dr P.Stockham, Forensic Science SA (SA) 

Amount awarded: $100,000.00